{"id": "1383134590152421377", "creation": 1618599958.0, "user_id": "1035185028152614913", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 36, "reply_count": 0, "like_count": 50, "quote_count": 1}}, "text": "A top #Cuban scientist tells MEDICC Review that using classical recombinant protein technology for Cuba\u2019s #COVID19 vaccines translates decades of experience into greater confidence in #vaccine safety. \nhttps://t.co/8PC1yHWQo4\n@BioCubaFarma @FinlayInstituto @centro_cim @CIGBCuba", "first_save": 1634559108.199414, "hashtags": ["#CUBAN", "#COVID19", "#VACCINE"]}